0.2999

2.64% +0.0077

After Hours: .2901 -0.0098 -3.27%

Aclarion Inc (ACON)

Overview News Price History Financials Discussions Forecast

Aclarion Inc stock is currently priced at $0.2999, with a 24-hour trading volume of 134.38K. It has seen a +2.64% increased in the last 24 hours and a +4.49% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.2947 pivot point. If it approaches the $0.3068 resistance level, significant changes may occur.

Previous Close:

$0.2922

Open:

$0.295

24h Volume:

134.38K

Market Cap:

$2.46M

Revenue:

$75,400

Net Income/Loss:

$-4.91M

P/E Ratio:

-0.5355

EPS:

-0.56

Net Cash Flow:

$-3.77M

1W Performance:

+1.15%

1M Performance:

+4.49%

6M Performance:

+36.32%

1Y Performance:

-76.75%

1D Range:

$0.291

$0.3094

52W Range:

$0.1811

$6.75

Aclarion Inc Stock (ACON) Company Profile

Name

Aclarion Inc

Sector

Healthcare (1204)

Industry

Health Information Services (65)

Phone

650-241-1741

Address

951 Mariners Island Boulevard, Suite 300, San Mateo

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ACON's Discussions on Twitter

Aclarion Inc Stock (ACON) Latest News

Ending PayTV Monopoly: A Clarion Call to Mike Adenuga – THISDAYLIVE - THISDAY Newspapers

THISDAY Newspapers

Ending PayTV Monopoly: A Clarion Call to Mike Adenuga – THISDAYLIVE - THISDAY Newspapers

THISDAY Newspapers

Ending PayTV Monopoly: A Clarion Call to Mike Adenuga – THISDAYLIVE - THISDAY Newspapers

THISDAY Newspapers

Heat wave in Delhi: A clarion call for climate action - BusinessLine

BusinessLine

Ending PayTV Monopoly: A Clarion Call to Mike Adenuga – THISDAYLIVE - THISDAY Newspapers

THISDAY Newspapers

Ending PayTV Monopoly: A Clarion Call to Mike Adenuga – THISDAYLIVE - THISDAY Newspapers

THISDAY Newspapers

Aclarion Inc Stock (ACON) Financials Data

Aclarion Inc (ACON) Revenue 2024

ACON reported a revenue (TTM) of $75.40 thousand for the quarter ending December 31, 2023, a +24.83% rise year-over-year.

Aclarion Inc (ACON) Net Income 2024

ACON net income (TTM) was -$4.91 million for the quarter ending December 31, 2023, a +30.52% increase year-over-year.

Aclarion Inc (ACON) Cash Flow 2024

ACON recorded a free cash flow (TTM) of -$3.77 million for the quarter ending December 31, 2023, a +26.98% increase year-over-year.

Aclarion Inc (ACON) Earnings per Share 2024

ACON earnings per share (TTM) was -$8.98 for the quarter ending December 31, 2023, a +38.27% growth year-over-year.

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.